Last year was not a good one for venture capital and private equity funds. Although there are now very few new projects in the pipeline, there could be as much as USD420m for them, particularly if they are medically orientated.
Last year was not a good one for venture capital and private equity funds. Although there are now very few new projects in the pipeline, there could be as much as USD420m for them, particularly if they are medically orientated.